Full name
PHARMAVITAE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
66.19.Z - Other activities supporting financial services, excluding insurance and pension funds
70.22.Z - Head office activities and management consultancy
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,1 | 0,2 | 1 | 541,1 |
EBITDA | 2,5 | 0,6 | 1,5 | 142,8 |
Short time liabilities | 15,8 | 9,2 | 17,5 | 90,3 |
Equity capital | 0,3 | 0,4 | 1,2 | 173,7 |
Operating profit (EBIT) | 2,4 | 0,5 | 1,3 | 192,1 |
Assets | 16,5 | 13,4 | 18,9 | 41,2 |
Net profit (loss) | 2,1 | 0,2 | 0,8 | 395,4 |
Cash | 0,4 | 1,8 | 1,1 | -39,9 |
Net income from sale | 37,7 | 60,1 | 75,1 | 24,9 |
Liabilities and provisions for liabilities | 16,3 | 12,9 | 17,6 | 36,6 |
Working assets | 14,7 | 11,4 | 17,7 | 55,7 |
Depreciation | 0,1 | 0,2 | 0,2 | 2,1 |
% | % | % | p.p. | |
Profitability of capital | 737,3 | 35,1 | 63,5 | 28,4 |
Equity capital to total assets | 1,7 | 3,3 | 6,4 | 3,1 |
Gross profit margin | 5,6 | 0,3 | 1,3 | 1 |
EBITDA Margin | 6,7 | 1 | 2 | 1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 153 | 56 | 85 | 29 |
Current financial liquidity indicator | 0.9289326071739197 | 1.236424207687378 | 1.012265920639038 | -0,2 |
Net dept to EBITDA | 4.6976637840271 | 9.87812614440918 | 4.617516994476318 | -5,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane